Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic
Open Access
- 17 July 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 26 (10), e118-e119
- https://doi.org/10.1093/ibd/izaa192
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Low risk of COVID-19 transmission in GI endoscopyGut, 2020
- Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryGastroenterology, 2020
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyGut, 2020
- Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, ChinaThe Lancet Gastroenterology & Hepatology, 2020
- Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and OutcomesThe American Journal of Gastroenterology, 2020
- Implications of COVID-19 for patients with pre-existing digestive diseasesThe Lancet Gastroenterology & Hepatology, 2020
- Engaging patients to improve quality of care: a systematic reviewImplementation Science, 2018
- The role of Patient Health Engagement Model (PHE-model) in affecting patient activation and medication adherence: A structural equation modelPLOS ONE, 2017
- A systematic review of the psychological correlates of adjustment outcomes in adults with inflammatory bowel diseaseClinical Psychology Review, 2016
- Measuring patient engagement: development and psychometric properties of the Patient Health Engagement (PHE) ScaleFrontiers in Psychology, 2015